199 related articles for article (PubMed ID: 30943747)
1. Drug-resistance reversal in colorectal cancer cells by destruction of flotillins, the key lipid rafts proteins.
Ye DM; Ye SC; Yu SQ; Shu FF; Xu SS; Chen QQ; Wang YL; Tang ZT; Pan C
Neoplasma; 2019 Jul; 66(4):576-583. PubMed ID: 30943747
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
3. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
4. 10-Gingerol Targets Lipid Rafts Associated PI3K/Akt Signaling in Radio-Resistant Triple Negative Breast Cancer Cells.
Ediriweera MK; Moon JY; Nguyen YT; Cho SK
Molecules; 2020 Jul; 25(14):. PubMed ID: 32664351
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of flotillin-2 impairs the proliferation of breast cancer cells through modulation of Akt/FOXO signaling.
Xie G; Li J; Chen J; Tang X; Wu S; Liao C
Oncol Rep; 2015 May; 33(5):2285-90. PubMed ID: 25738752
[TBL] [Abstract][Full Text] [Related]
6. A Novel Role for Flotillin-Containing Lipid Rafts in Negative-Feedback Regulation of Thyroid-Specific Gene Expression by Thyroglobulin.
Luo Y; Akama T; Okayama A; Yoshihara A; Sue M; Oda K; Hayashi M; Ishido Y; Hirano H; Hiroi N; Katoh R; Suzuki K
Thyroid; 2016 Nov; 26(11):1630-1639. PubMed ID: 27676653
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
8. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
[TBL] [Abstract][Full Text] [Related]
9. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
10. CXCL12-induced partitioning of flotillin-1 with lipid rafts plays a role in CXCR4 function.
Giri B; Dixit VD; Ghosh MC; Collins GD; Khan IU; Madara K; Weeraratna AT; Taub DD
Eur J Immunol; 2007 Aug; 37(8):2104-16. PubMed ID: 17634952
[TBL] [Abstract][Full Text] [Related]
11. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.
Arcaro A; Aubert M; Espinosa del Hierro ME; Khanzada UK; Angelidou S; Tetley TD; Bittermann AG; Frame MC; Seckl MJ
Cell Signal; 2007 May; 19(5):1081-92. PubMed ID: 17275257
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-Kinase dependent upregulation of the epidermal growth factor receptor upon Flotillin-1 depletion in breast cancer cells.
Kurrle N; Ockenga W; Meister M; Völlner F; Kühne S; John BA; Banning A; Tikkanen R
BMC Cancer; 2013 Dec; 13():575. PubMed ID: 24304721
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes.
Calay D; Vind-Kezunovic D; Frankart A; Lambert S; Poumay Y; Gniadecki R
J Invest Dermatol; 2010 Apr; 130(4):1136-45. PubMed ID: 20054340
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway.
Dong W; Wang F; Liu Q; Wang T; Yang Y; Guo P; Li X; Wei B
Recent Pat Anticancer Drug Discov; 2022; 17(2):178-186. PubMed ID: 34365931
[TBL] [Abstract][Full Text] [Related]
15. Methyl-β-cyclodextrin potentiates the BITC-induced anti-cancer effect through modulation of the Akt phosphorylation in human colorectal cancer cells.
Yang Q; Miyagawa M; Liu X; Zhu B; Munemasa S; Nakamura T; Murata Y; Nakamura Y
Biosci Biotechnol Biochem; 2018 Dec; 82(12):2158-2167. PubMed ID: 30200817
[TBL] [Abstract][Full Text] [Related]
16. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
17. The lipid raft proteins flotillins/reggies interact with Galphaq and are involved in Gq-mediated p38 mitogen-activated protein kinase activation through tyrosine kinase.
Sugawara Y; Nishii H; Takahashi T; Yamauchi J; Mizuno N; Tago K; Itoh H
Cell Signal; 2007 Jun; 19(6):1301-8. PubMed ID: 17307333
[TBL] [Abstract][Full Text] [Related]
18. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
19. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
[TBL] [Abstract][Full Text] [Related]
20. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM
Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
